Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Total 13F shares
-
11,402,706
-
Share change
-
-356,649
-
Total reported value
-
$10,374,424
-
Put/Call ratio
-
14%
-
Price per share
-
$0.91
-
Number of holders
-
49
-
Value change
-
-$452,161
-
Number of buys
-
15
-
Number of sells
-
25
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q1 2025
As of 31 Mar 2025,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,402,706 shares.
The largest 10 holders included
Bleichroeder LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., Robertson Stephens Wealth Management, LLC, Sigma Planning Corp, BANK OF AMERICA CORP /DE/, ADVISORY RESEARCH INC, STIFEL FINANCIAL CORP, and NORTHERN TRUST CORP.
This page lists
49
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.